pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
396
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
clindamycin palmitate hydrochloride
Clindamycin Palmitate Hydrochloride
Skin And Soft Tissue Infections
Somerset Therapeutics LLC
Marketed
colistimethate sodium
Colistimethate Sodium
Lower Respiratory Tract Infections
Xellia Pharmaceuticals USA LLC
Phase 2
comekibart
comekibart [INN]
Atopic Dermatitis (Atopic Eczema)
Shanghai Mabgeek Biotechnology Co Ltd
← prev
page 10 of 14
next →
Pain
89
Neurology
1
Marketed
cyproheptadine hydrochloride
Cyproheptadine Hydrochloride
Vasomotor Rhinitis
Boscogen Inc
Marketed
cysteamine DR
Procysbi (cysteamine)
Nephropathic Cystinosis
Horizon Therapeutics USA Inc
Phase 2
dactolisib tosylate + everolimus
dactolisib tosylate + everolimus
Respiratory Tract Infections
$ACET
Adicet Bio, Inc.
Marketed
delafloxacin meglumine
Baxdela (delafloxacin meglumine)
Skin And Skin Structure Infections (SSSI) Caused By Bacteria
Melinta Therapeutics LLC
Marketed
demeclocycline hydrochloride
Demeclocycline Hydrochloride
Acne Vulgaris
Epic Pharma LLC
Marketed
desloratadine
Desloratadine
Chronic Urticaria
Belcher Pharmaceuticals LLC
Phase 2
deupirfenidone
deupirfenidone
Idiopathic Pulmonary Fibrosis
Celea Therapeutics
Phase 3
dexamethasone sodium phosphate
SEMDEXA (dexamethasone sodium phosphate)
Ataxia-Telangiectasia (Louis-Bar Syndrome)
$QNCX
Quince Therapeutics, Inc.
Marketed
dexchlorpheniramine maleate
RyClora (dexchlorpheniramine maleate)
Angioedema
Carwin Pharmaceutical Sales LLC
Marketed
dextromethorphan
Elixsure DM (dextromethorphan [INN])
Cough
Moberg Pharma AB
Marketed
dicloxacillin sodium
Dicloxacillin Sodium
Bacterial Pneumonia
Teva Pharmaceuticals USA Inc
Marketed
dornase alfa
Pulmozyme (dornase alfa)
Cystic Fibrosis
Genentech Inc
Marketed
doxapram hydrochloride
Doxapram Hydrochloride
Chronic Obstructive Pulmonary Disease (COPD)
Chartwell Pharmaceuticals LLC
Marketed
durlobactam sodium + sulbactam sodium
Xacduro (durlobactam sodium + sulbactam sodium)
Hospital Acquired Pneumonia (HAP)
Entasis Therapeutics Holdings Inc
Marketed
dyclonine
Dyclopro (dyclonine [INN])
Pharyngitis
Septodont Inc
Phase 2
efdoralprin alfa
efdoralprin alfa [INN]
Alpha-1 Antitrypsin Deficiency (A1AD)
$SNY
Sanofi
Phase 2
efzofitimod
efzofitimod [INN]
Interstitial Lung Diseases (Diffuse Parenchymal Lung Dise…
$ATYR
aTYR PHARMA INC
Phase 2
elifactant
elifactant
Neonatal Respiratory Distress Syndrome
Chiesi Farmaceutici SpA
Phase 2
enamptcumab
eNamptor
Acute Respiratory Distress Syndrome
Aqualung Therapeutics Corp
Marketed
ensifentrine
Ohtuvayre (ensifentrine)
Bronchiectasis
Verona Pharma Ltd
Marketed
ertapenem sodium
Ertapenem Sodium
Community-Acquired Bacterial Pneumonia
Fosun Pharma USA Inc
Phase 3
florensocatib
florensocatib
Bronchiectasis
Chiesi Farmaceutici SpA
Marketed
flucytosine
Ancobon (flucytosine)
Cryptococcal Meningitis
Bausch Health US LLC
Marketed
flunisolide
Flunisolide
Asthma
Riconpharma LLC
Marketed
formoterol fumarate
Perforomist (formoterol fumarate)
Chronic Bronchitis
Mylan Specialty LP
Phase 2
galicaftor
galicaftor
Cystic Fibrosis
$SION
Sionna Therapeutics, Inc.
Phase 2
genistein
genistein
Pulmonary Fibrosis
Humanetics Corp
